Ken Zou, Truman Koh, Heather Wolfe, Farrukh Awan. "Acalabrutinib monotherapy versus acalabrutinib plus obinutuzumab combination therapy in treatment-naïve chronic lymphocytic leukemia: A ‘real-world’ study of efficacy and safety at a tertiary academic medical center." Blood, 2025. doi:10.1182/blood-2025-4558